Researchers at the University of British Columbia have uncovered a direct connection between high insulin levels and the onset of pancreatic cancer in a recent mouse study, shedding light on a potential pathway for prevention and treatment strategies. Pancreatic cancer, with a 5-year survival rate of less than 10%, remains one of the deadliest cancers, partly due to the limited eligibility for surgical intervention at diagnosis.
The study, published in Cell Metabolism, explores how hyperinsulinemia—a condition characterized by excessive insulin in the body commonly seen in individuals with obesity and type 2 diabetes—can lead to pancreatic cancer. This condition was found to increase the production of digestive enzymes in the pancreas, which, when overproduced, can cause pancreatic inflammation and the formation of precancerous cells.
This groundbreaking research not only clarifies the mechanism by which high insulin levels contribute to pancreatic cancer but also opens up avenues for targeted research in other cancers potentially influenced by hyperinsulinemia. The findings could lead to the development of precision medicine and dietary interventions aimed at reducing the risk and improving the management of pancreatic and possibly other insulin-related cancers.
Experts suggest that understanding the role of insulin in cancer development is crucial, as insulin is one of the most actionable hormones. Future research directions include exploring the effects of high insulin on established cancers, investigating insulin’s impact on other types of cancer, and identifying specific drugs for insulin-driven cancers.
Additionally, studying the response of human pancreatic tumors to high insulin and sugar levels could further elucidate the link between diet, insulin levels, and cancer risk.
This study emphasizes the importance of a healthy lifestyle, including a diet rich in fruits and vegetables, regular exercise, and avoiding risk factors like smoking and excessive alcohol consumption, in lowering the risk of pancreatic cancer and potentially other insulin-related cancers.
Source: Medical News Today
Image by Tibor Janosi Mozes from Pixabay
